Gemtesa 75 MG tablet 90S
Ended Awarded
- Contract number
- SPE2DB25FMYBD
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $3,329
Award facts
- Contract value 100% obligated
- $3,328.73 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Gemtesa 75 mg tablets (90-count) under a firm fixed price contract valued at $3,328.73. The award, issued on August 18, 2025, with an ultimate completion date of August 19, 2025, represents a competitive, non-set-aside procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the place of performance and is a major pharmaceutical distributor providing critical medical supplies to federal healthcare systems, particularly military and veteran programs.
This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, which carries a maximum value of $999,999,999.00 and extends through December 2026. This prime contract vehicle supports global pharmaceutical supply requirements across multiple therapeutic domains for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. Gemtesa (mirabegron) is a prescription medication used to treat overactive bladder, reflecting the company's comprehensive portfolio of specialty medications and branded pharmaceuticals supplied through the DLA Medical Supply Chain to support military healthcare operations worldwide.
Quick answers
Who was awarded contract SPE2DB25FMYBD?
SPE2DB25FMYBD was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 18, 2025.
How much is contract SPE2DB25FMYBD worth?
The government has obligated $3,329 on SPE2DB25FMYBD.
Is contract SPE2DB25FMYBD an order under another contract?
Yes. SPE2DB25FMYBD is a delivery order under SPE2DB20D2104, an indefinite delivery contract.
Was contract SPE2DB25FMYBD competed?
The extent of competition for SPE2DB25FMYBD was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award